Clinical Trials
209 trialsGame-Based Intervention to Promote HPV Vaccination
Michigan State University
Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs
University of California, Los Angeles
SHARP
Johns Hopkins Bloomberg School of Public Health
V503-024
Merck Sharp & Dohme LLC
Communication Strategies to Increase HPV Vaccination Intention
University of Pennsylvania
PREVENT Pilot HPV - Related Cancers Trial
University of Utah
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer
Mayo Clinic
Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)
Merck Sharp & Dohme LLC
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
Radiation Therapy Oncology Group
HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults
Mayo Clinic
PAPILOCAN
Procare Health Iberia S.L.
HPV-VG1
Ruhr University of Bochum
Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalachia
Ohio State University Comprehensive Cancer Center
PRESTIS
Baylor College of Medicine
Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions
Barinthus Biotherapeutics
HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini
Columbia University
HPV-Based Screen-and-Treat Demonstration Project in Lilongwe
UNC Lineberger Comprehensive Cancer Center
HPV
POSVAX
Isbaar
University of Minnesota
1:1 Comparison of the Pocket Colposcope in Kenya
Duke University
Efficacy of Probiotic Lactobacillus Crispatus M247 in Promoting High-risk Human Papillomavirus (HR-HPV) Infection Clearance and Modifying Vaginal Microbiota
Liaquat University of Medical & Health Sciences
V503-066
Merck Sharp & Dohme LLC
What is the Optimal Training Model for Cervical Awareness?
Izmir City Hospital
PREVENT
University of Utah
Interferon Alpha Therapy for Cervical CINI and HPV Infection
Mongolian National University of Medical Sciences
TRAP-HPV
McGill University
The Effect of Natural Molecules on HPV Infection
AGUNCO Obstetrics and Gynecology Centre
Intervention for Human Papillomavirus Vaccine Acceptance in Mexican Mothers
Hospital Univeristario Benemerita Universidad Autonoma de Puebla
COVE-1
Verrica Pharmaceuticals Inc.
CARE-1
Verrica Pharmaceuticals Inc.
Web-Based Education Program and Educational Booklet Developed on Cervıcal Cancer
Istanbul University - Cerrahpasa
Anal HPV Infection and Risk for Anal High-grade Squamous Intraepithelial Lesion Among Thai MSM With Acute HIV Infection
Thai Red Cross AIDS Research Centre
PALOMA2
Procare Health Iberia S.L.
PROMOTE
Fred Hutchinson Cancer Center
HPV Typing Between Self- and Physician-sampled
Hygeia Touch Inc.
OPTIMA
University of Chicago
HPV Vaccination Health-promotion Programme on Vaccine Acceptance and Uptake Among Female Adolescents
Chinese University of Hong Kong
ANCHOR
AIDS Malignancy Consortium
Identification and Treatment of Cervical Abnormalities in Perú Through Integration of Pocket Colposcopy and Telemedicine
Duke University
EEWCCKAB
Kahramanmaras Sutcu Imam University
ALA-PDT in Patients With CIN2 in p16-positivity and High-risk HPV Infection
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
HPV Decide
The University of Texas Health Science Center at San Antonio
Vaccine Therapy in Preventing HPV in HIV-Positive Women in India
AIDS Malignancy Consortium
PRESCRIP-TEC
University Medical Center Groningen
HPV Vaccine Immunity in High-risk Women
Murdoch Childrens Research Institute
Clinic or Self-Sampling for Cervical Cancer Screening
Istanbul University - Cerrahpasa
Video-Assisted Counseling for HPV Vaccination
Le Bonheur Children's Hospital
Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents
University of Washington
Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Shanghai Bovax Biotechnology Co., Ltd.